Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events eu grants largest project safety evaluation drugs used treatment diabetes
… negotiate - for the first time - pricing for certain drugs. The Maximum Fair Price (MFP) negotiations include certain high-expenditure, single-source drugs or biologic products with no generic or biosimilar … or work with a partner who does. The top 50 drugs with the highest total expenditures for the 12-month …
… with our clients on projects to research cancer, cancer treatment, and complications and comorbidities of cancer. Our … products to treat cancer and complications arising from treatment of cancer illnesses. Recent projects have included: … outcomes (PRO) strategy Preparation of HTA submissions Safety surveillance studies Stated preference and …
… of ICER'S evidence ratings in evidence reports for new drugs in 2020 and 2021. Ronquest N , Clinkscales M, Paret K. … ICER’s value assessment framework is similar to frameworks used by major global HTA bodies. However, ICER’s method for … improvement in clinical outcomes without longer-term safety evidence OR less impressive efficacy with longer-term …
… dynamic in nature and updated every year. It is the most used deliverable of ENCePP with more than 10,000 views and … of valid and reliable studies on the effectiveness and safety of treatments and vaccines and, ultimately, to the …
… Support to secure regulatory acceptability of COAs Evaluation of feasibility and acceptance for routine clinical …
… Outcome Instruments for Use in Medical Device Evaluation.” While its title suggests that the draft … offers several recommendations related to the development, evaluation, and regulatory review of clinical outcome … a study’s primary endpoint, inclusion criteria, or a safety outcome. When developing new instruments, …
… to research infectious disease, infectious disease treatment, and complications and comorbidities of infectious … treat infectious diseases and complications arising from treatment of infectious diseases. Recent projects have … access kits Stated preference studies Survey development, evaluation and implementation Treatment patterns and patient …
… of Value & Access, Europe RTI Health Solutions With the EU's developing guidelines designed to standardise and bring … Because small molecules or multiple-indication orphan drugs are disincentivised by the Inflation Reduction Act … workload and the uncertainties around the initial EU JCAs. Companies could find choosing to pursue research for …
… Understanding Treatment Trends for Chronic Lymphocytic Leukemia Time trends … chronic lymphocytic leukemia or CLL. To better understand treatment trends, we undertook a retrospective cohort study … study includes nearly 1400 patients receiving their first treatment during July 2012 to June 2016. The combination of …
… we’ve acquired from working on hundreds of different drugs in nearly every therapeutic area to help commercialize … including direct, indirect, and intangible costs; cost of treatment and health-related quality of life; healthcare resource utilization Treatment Patterns Medication adherence, persistence, and …